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Abstract
Microglia and macrophages are recruited to sites of retinal degeneration where local cytokines and chemokines determine
protective or neurotoxic microglia responses. Defining the role of Ccl2-Ccr2 and Cx3cl1-Cx3cr1 signalling for retinal
pathology is of particular interest because of its potential role in age-related macular degeneration (AMD). Ccl2, Ccr2, and
Cx3cr1 signalling defects impair macrophage trafficking, but have, in several conflicting studies, been reported to show
different degrees of age-related retinal degeneration. Ccl2/Cx3cr1 double knockout (CCDKO) mice show an early onset
retinal degeneration and have been suggested as a model for AMD. In order to understand phenotypic discrepancies in
different chemokine knockout lines and to study how defects in Ccl2 and/or Cx3cr1 signalling contribute to the described
early onset retinal degeneration, we defined primary and secondary pathological events in CCDKO mice. To control for
genetic background variability, we compared the original phenotype with that of single Ccl2, Cx3cr1 and Ccl2/Cx3cr1 double
knockout mice obtained from backcrosses of CCDKO with C57Bl/6 mice. We found that the primary pathological event in
CCDKO mice develops in the inferior outer nuclear layer independently of light around postnatal day P14. RPE and vascular
lesions develop secondarily with increasing penetrance with age and are clinically similar to retinal telangiectasia not to
choroidal neovascularisation. Furthermore, we provide evidence that a third autosomal recessive gene causes the
degeneration in CCDKO mice and in all affected re-derived lines and subsequently demonstrated co-segregation of the
naturally occurring RD8 mutation in the Crb1 gene. By comparing CCDKO mice with re-derived CCl22/2/Crb1Rd8/RD8,
Cx3cr12/2/Crb1Rd8/RD8 and CCl22/2/Cx3cr12/2/Crb1Rd8/RD8 mice, we observed a differential modulation of the retinal
phenotype by genetic background and both chemokine signalling pathways. These findings indicate that CCDKO mice are
not a model of AMD, but a model for an inherited retinal degeneration that is differentially modulated by Ccl2-Ccr2 and
Cx3cl1-Cx3cr1 chemokine signalling.
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Introduction
Mononuclear phagocytes (dendritic cells, macrophages, and
microglia) are part of the myeloid cell lineage and are effector cells
of the innate immune system. These cells all express CX3CR1 and
are thought to be derived from different circulating monocyte
populations [1–3]. In virtually all tissues, including the uveal tract
of the eye, these cells form a network of resident dendritic cells and
macrophages that is important for local immune surveillance and
control of tissue homeostasis [3–5]. Microglia are the resident
macrophages of the central nervous system including the retina
and are located throughout the neural parenchyma (parenchymal
microglia cells) and surrounding blood vessels (perivascular
microglia cells) [6–9]. Resting microglia exhibit continuous,
dynamic surveillance behaviour and maintain stable soma position
[10,11]. During acute and chronic degenerative changes in the
retina, microglia as well as systemic macrophages become
activated and are recruited to the site of tissue damage [12].
Such activation and recruitment of microglia and macrophages
has been described in the retina during acute focal blue light
damage [12], laser induced choroidal neovascularisation (CNV)
[13], inherited retinal degenerations [9,14], constant light
exposure [15] as well as in other chronic inflammatory or para-
inflammatory processes such as normal ageing [16,17]. The local
responses of microglia and macrophages are controlled by levels of
cytokines and chemokines in the microenvironment which also
define the heterogeneous activation state of these cells that can be
pro-inflammatory (classical activation), cell or tissue protective
(alternative activation) or immune suppressive [18–20]. In recent
years, the two chemokine signalling pathways CCL2-CCR2 and
CX3Cl1-CX3CR1, have become a major focus of ophthalmolog-
ical research because of their proposed role in age-related macular
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degeneration (AMD), one of the most common causes for
blindness in the elderly [21,22]. CCL2-CCR2 signalling is one
of the major pro-inflammatory pathways that controls transen-
dothelial migration and recruitment of pro-inflammatory CCR2-
expressing monocytes to sites of inflammation [23–25]. CX3CL1-
CX3CR1 signalling controls the trafficking of patrolling mono-
cytes [26] and regulates the communication of Cx3cr1 expressing
microglia with neurons and glia in the nervous system to limit
microglia-mediated neurotoxicity [23,26–28]. In the retina, both
pathways also control the dynamics and re-distribution of resting
microglia during surveillance, activation/polarisation in response
to acute injury or increased light and during ageing [15,29,30].
But it remains unresolved how these two signalling pathways
interact in retinal degenerations and how defects in the pathways
in the context of environmental (e.g. light) or endogenous (retinal
degeneration) stress might alter the activation state of microglia or
systemically derived macrophages and thereby might contribute to
retinal pathology including photoreceptor and RPE degeneration
during age-related retinal degeneration.
An important role of these two chemokine pathways in AMD
has been supported by the identification of variants of the
chemokine receptor gene CX3CR1 as a genetic risk factor for
AMD [29,31]. However, this genetic association with AMD risk
has not been reproduced in recent genome wide association and
case-control studies [32–34]. Additional evidence for an important
functional role of chemokine signalling during ageing and in AMD
came from the observation of reduced expression of CX3CR1 in
non classical monocytes and an increased serum level of CCL2
with age [35]. In addition, aqueous humor samples from AMD
patients with exudative late stage AMD show also higher levels of
CCL2 compared with controls [36]. Overall, this suggests that
CX3CR1 and CCL2 chemokine signalling pathways not only play
a role during normal ageing, but may be involved in the
pathogenesis of AMD.
Several conflicting studies on single chemokine knockout mice
for Ccl2, Ccr2 or Cx3c1 have reported that the abnormal trafficking
and function of macrophages and microglia in these models is
associated with a variable degree of age-related retinal and RPE
degeneration [29,37,38]. A consistently described feature of all
these chemokine knockout models are opaque yellow-white
discrete spots in normal bright light fundus images. This
phenotype has led to the misleading description of these mice as
exhibiting drusen-like lesions and to the hypothesis that these mice
represent models of general AMD pathology [29,37]. The origin
of the fundus lesions have recently been demonstrated to be
bloated lipofuscin containing macrophages or microglia in the
subretinal space that slowly accumulate with age [39,40].
The age-related accumulation of subretinal macrophages in
Ccl2, Ccr2 and Cx3cr1 knockout mice shows that chemokine
signalling defects lead to dysfunctional macrophages in the retina.
However, the contributory role of these dysfunctional macro-
phages to photoreceptor or RPE degeneration is not clear. Some
groups have not observed significant age-related retinal and RPE
degeneration or any spontaneous CNV in Ccl2 knockout mice
[40], while other groups have reported a variable penetrance of
age-related photoreceptor and RPE degenerations as well as the
spontaneous development of CNV in Ccl2 and Ccr2 single
knockout mice [37,38]. In Cx3cr1 knockout mice, accumulation
of subretinal macrophages/microglia is associated with a marked,
progressive age-related retinal degeneration. This suggests that
Cx3cr1 signalling may play a more pronounced role for survival of
photoreceptors and the RPE, while the role of Ccl2 in this process
remains unresolved [29,40]. Overall these conflicting results
suggest that additional factors contribute to the observed
degenerative processes in chemokine knockout mice. These might
involve environmental conditions such as housing, light, infection/
pathogen burden and diet. Furthermore, Ccl2/Cx3cr1 double
knockout mice have been described as developing a more
accelerated and severe, early onset retinal phenotype with high
penetrance of rapid photoreceptor loss and RPE defects, which
suggested that the combined knockout of both chemokine
signalling pathways might act synergistically and may thus lead
to an early onset retinal degeneration [41]. Since the original
report, these mice have been studied by a number of laboratories
and are considered to be a reasonable model for chemokine-
mediated pathological processes contributing to AMD pathology.
Several anti-inflammatory and anti-oxidative treatment approach-
es, e.g. with omega-3 fatty acids [42] as well as anti-VEGF [43]
treatment have been reported to reduce lesion development in this
mouse line.
In order to understand the reported phenotypic discrepancies in
the different chemokine knockout mouse models and to study how
defects in the two Ccl2 and Cx3cr1 signalling pathways may
contribute to the development of the early onset retinal
degeneration, we aimed to define primary and secondary
pathological events during the age-related progression of the
degeneration in CCDKO mice between 2 weeks and 22 months of
age [41]. To control for genetic background variability, which
might account for some of the reported phenotypic variability in
retinal degenerations of chemokine knockout mice, we established
single Ccl2, single Cx3cr1 and double Ccl2/Cx3cr1 knockout mice
from the original CCDKO mouse line by backcrossing with C57Bl/
6mice. We housed all these lines under same lighting conditions in
the same room to control for environmental factors including
pathogen burden and in addition raised some CCDKO mice in
darkness from birth. Through these experiments, we identified the
primary pathological event in CCDKO mice in the outer nuclear
layer of the retina and established the Crb1RD8/RD8 mutation as a
third independent autosomal recessive locus as the cause for the
early onset retinal degeneration which was not dependent on light.
Furthermore, we observed differential modulatory effects of the
genetic background, as well as of both chemokine signalling
pathways on the manifestation of the early onset retinal
degeneration and therefore show that CCDKO mice are not a
model for AMD pathology. These finding also highlight a
differential modulatory role of Ccl2-Ccr2 and Cx3cl1-Cx3cr1
chemokine signalling for retinal degeneration.
Materials and Methods
Animals and housing conditions
Ccl2/Cx3cr1 double knockout mice (CCDKO mice) used in this
study were derived from two breeding pairs (2 females and 2
males) that we obtained from the original line as described by Tuo
et al. and were thankfully provided by Chi-Chao Chan and
Jingsheng Tuo [41]. According to this publication the line was
mainly of C57Bl/6 background [41]. These animals were initially
kept as a homozygous line under a normal 12-hour light-dark
cycle. The mean luminescence during the light period at the level
of bottom of the cage was 33628 lx. Furthermore, the animals
have access to cover (e.g. paper roll and excess of bedding) inside
the cage which allows them to burrow. For dark housing (darkness
luminescence ,0.5 lx), pregnant female mice were transferred
into a ventilated housing cabinet (Scantainer I-110, Scanbur,
Denmark) which was further modified in house to reduce light
exposure from the outside. Dark-housed animals were born in
darkness and kept in the cabinet for 8 weeks before analysis.
Animal husbandry was performed under red light (emission
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spectrum above 600 nm, red lamp, #02580, British Electrical
Lamps Limited, UK).
As control animals we used age-matched C57Bl/6J OLA Hsd
mice (Harlan UK Ltd., Blackthorn, UK) that were imported as
young adult mice at 6–8 weeks of age and housed in the same
animal rooms next to CCDKO mice. For backcrossing experiments,
CCDKO mice from our original homozygous line and C57Bl/6J
Ola Hsd mice were used as founder animals (F0). Obtained
offspring (F1) that were heterozygous for both, the Ccl2 and the
Cx3cr1 alleles were interbred to obtain the F2 generation. F2-
animals were genotyped for both cytokine loci and interbred with
each other to establish new lines for all combination of cytokine
genotypes that include homozygous wildtype (Ccl2+/+/Cx3cr1+/+)
mice, new single knockout mice for Ccl2 (Ccl22/2/Cx3cr1+/+) or
Cx3cr1 (Ccl2+/+/Cx3cr12/2) as well as a new double knockout line
for both Ccl2 and Cx3cr1 (Ccl22/2/Cx3cr12/2).
For in vivo procedures, mice were anesthetized by a single
intraperitoneal (IP) injection of a mixture of medetomidine
hydrochloride (1 mg/kg body weight; Domitor; Pfizer Animal
Health, New York, NY), and ketamine (60 mg/kg body weight) in
water. Whenever necessary, the pupils were dilated with 1 drop of
1% tropicamide. The animal experiments were performed in
accordance with the ARVO Statement for the Use of Animals in
Ophthalmic and Vision Research and under the UK Home Office
project licence (PPL 70/1279).
Genotyping
Genotyping PCR for the cytokine loci were performed using Go
Tag Ready Green Mix (M712, Promega, Southampton, UK)
using primer combinations distinguishing the wildtype and
knockout alleles for Ccl2 and Cx3cr1 respectively (table 1) [44].
Genotyping of the RD8 (retinal degeneration 8) allele carrying a
single base pair deletion (DC) in exon 9 of the Crb1 gene was
confirmed by PCR amplification using flanking primers and
subsequent sequencing (table 1).
Autofluorescence imaging and phenotyping of mice
using scanning laser ophthalmoscopy
Autofluorescence imaging was performed using a HRA2
scanning laser ophthalmoscope with a 55u angle lense as described
previously [40]. We used the autofluorescent mode of the HRA2
(Heidelberg engineering, Heidelberg, Germany) to scan the retina
with a 488 nm laser that provides the excitation light to stimulate
emission of autofluorescence from any possible fluorophores in the
retina including e.g. lipofuscin in the RPE. The optic disc was
positioned at the center of the image and the image focused either
on the inner retinal vasculature, the inner retinal layer or the outer
retina respectively. Projection images of 30 frames per fundus were
taken and evaluated for the appearance of autofluorescence.
To phenotype offspring during backcrosses for retinal degener-
ation, we used fundus images focused on the inner retinal layer
and evaluated the phenotype of the animals qualitatively using the
red free (barrier filter at 500 nm) and the autofluorescent channels
of the HRA2. To more quantitatively evaluate the severity of the
phenotype, we subsequently counted the number of autofluor-
escent lesions per fundus image in the autofluorescent images for
each animal after these had been processed in Adobe Photoshop
CS 2 (Adobe Systems Incorporated, UK) using the auto level
function. These counts include not only the typical disciform
autofluorescent lesions from the inferior retina, but also include
any autofluorescent signal from the whole fundus image including
those from the superior retina.
Optical coherence tomography (OCT) and fundus
fluorescein angiography (FFA)
OCT imaging and fundus fluorescein angiography were
performed during the same session using either the SpectralisTM
HRA+OCT (Heidelberg engineering, Heidelberg, Germany) for
OCT imaging or the HRA2 for fundus fluorescein angiography.
First OCT images were obtained from the animals using OCT+IR
or OCT+AF channels to correlate the retinal position with the
obtained two-dimensional optical section obtained by the OCT.
Subsequently, the same animals were injected intraperitoneal with
200 ml of 2% fluorescein in phosphate buffered saline (PBS) and
fundus fluorescein angiography images were taken using the
autofluorescent channel of the HRA2 equipped with an Argon
laser at 488 nm wavelength. Obtained 2-dimensional OCT
images and autofluorescent fundus images were exported and
processed in Adobe Photoshop CS 2 (Adobe Systems Incorporat-
ed, San Jose, USA).
Histopathology and pathology grading
Semithin histological morphometric analyses were performed as
described previously [40]. Animals were sacrificed at the respective
age and cardiac perfusion with 1%PFA was performed before the
eyes were enucleated and fixed in 3% glutaraldehyde and 1%
paraformaldehyde in 0.08 M sodium cacodylate-HCl (pH 7.4) for
at least 30 hours at 4uC. The cornea and lens were removed and
the eye cups oriented and post fixed in 1% aqueous osmium
tetroxide for 2 hours, dehydrated by an ascending ethanol series
(50%–100%) and propylene oxide, and infiltrated overnight with a
1:1 mixture of propylene oxide. After 8 hours in full resin, the eyes
were embedded in fresh resin and incubated overnight at 60uC.
Semithin (0.7 mm) sections were cut in the inferior–superior axis
passing through the optic nerve head with a microtome (Ultracut
S; Leica, Wetzlar, Germany). Semithin sections were stained with
a 1% mixture of toluidine blue-borax in 50% ethanol and images
taken using bright field microscopy (Oberserver.Z1 Axio, Carl
Zeiss Microimaging, Jena, Germany).
To evaluate the pathological changes in the retina and the RPE
over time sections from age-matched CCDKO and C57Bl/6
wildtype mice between 2 weeks and 22 months of age were
assessed under bright field microscopy using a 1006objective and
a 106ocular lense. Singular pathological events in the retina (e.g.
misplacement of nuclei from the outer nuclear layer toward the
inner or outer retina or disorganized photoreceptor columns) and
in the RPE (e.g. cell lysis, pyknosis, swelling, thinning, proliferation
Table 1. PCR primer for genotyping of Ccl2 and Cx3cr1 alleles
and for amplification of the RD8 locus for sequencing.
Gene Allele Primer name 59 – 39 sequence
Ccl2 Wildtype mmMCP1 ex1 for1 ctgtcatgcttctgggcctg
mmMCP1 ex2 R1 cttgctggtgaatgagtagc
Ccl2 Knockout MCP1 Neo Reverse ctaggggaggagtagaaggtg
mmMCP1 ex2 R1 cttgctggtgaatgagtagc
Cx3cr1 [44] Wildtype Cx3cr1 WTP ggcctgttatttgggcgacat
Cx3cr1 ASP tggggtgacgccactaagat
Cx3cr1 [44] Knockout Cx3cr1 KOP gaccgcttcctcgtgcttta
Cx3cr1 ASP tggggtgacgccactaagat
Crb1 RD8 mCrb1 F1 gcacaatagagattggaggc
mCrb1 R1 tgtctacatccacctcacag
doi:10.1371/journal.pone.0035551.t001
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and thickening of RPE) were counted form the superior to the
inferior end of the retina in each section. From these individual
sums of damages per section we calculated the mean sum of outer
nuclear and RPE damage from three sections per animal to obtain
a representative measure of outer retinal or RPE damage score per
animal similar to a scheme described by Hollyfield et al. and us
[40,45].
Ultrastructural analysis using serial block-face scanning
electron microscopy- (SB_SEM) with Gatan 3View
For 3-D analyses retinae fixed in 3% glutaraldehyde and 1%
paraformaldehyde buffered to pH 7.4 with sodium cacodylate
were rinsed in buffer, and then osmicated, en bloc stained with
uranyl acetate and Waltons lead citrate using the method of West
et al. [46] with two minor modifications. First, we reduced the
osmium concentration to 1% and second, employed propylene
oxide as a transition solvent between absolute alcohol and
Durcupan ACM resin.
Regions of interest (ROI) were cut from resin blocks following
normal surveying by LM and TEM of toluidine blue stained
semithin sections and unstained ultrathin sections. The isolated
ROI’s were then superglued onto a Leica cryopin, re-trimmed to
place the region of interest within a mesa of height ,1 mm and
side 0.5 mm and sputter coated with 5 nm gold palladium. Next,
the specimen was locked into the specimen holder of the Gatan 3
View ultramicrotome mounted to the opened chamber door of a
Zeiss Sigma variable pressure field emission scanning electron
microscope and the diamond knife advanced until the full face of
the block was being sectioned at 200 nm increments. At this point
the microscope was evacuated and the block face imaged using
Gatan’s low voltage backscatter detector at 2–4 kV and chamber
pressure of 10–30 Pa to suppress charging artifacts. Finally the
pixel dwell time, magnification and chamber pressure were
optimised to yield a focused ROI and the microtome programmed
to automatically cut a maximum of 9996100 nm thick sections
with intervening image acquisitions. In this way a stack of 999
images spanning an axial distance of 99.9 mms were digitally
acquired at 409664096 pixel resolution in Digital Micrograph
format. Three-dimensional reconstruction and labeling of the
vascular lumen and Bruch’s membrane was obtained using the
Amira 5.3.3 software (Visage Imaging Inc., Berlin, Germany).
Immunohistochemistry
Eyes for retinal and RPE/choroidal flat mounts were briefly
fixed in 4% paraformaldehyde (PFA)/PBS before dissection and
post-fixed again in 4% PFA/PBS for a total of 1 hour. After
blocking with PBS/1% BSA (Sigma Aldrich, Steinheim, Ger-
many)/5% nonspecific goat serum (AbD Serotec, Kidlington, UK)
including 0.3% Triton X-100 for permeabilisation for 1 hour the
flat mounts were incubated over night at 4uC with a 1:500 dilution
of anti Iba1 antibody (final concentration= 1 mg/ml, Code
No. 019-19741, WAKO, Osaka, Japan) in blocking solution to
label microglia and with primary TRITC-conjugated lectin at a
1:10 dilution (final concentration= 0.1 mg/ml, L5264 Sigma
Aldrich, Steinheim, Germany) to label endothelial cells. After
washing with 3–4 times with PBS, 1:500 dilution of goat anti-
rabbit AlexaFluor 488 nm-conjugated secondary antibody (final
concentration 4 mg/ml, #A11034; Invitrogen-Molecular Probes,
Leiden, The Netherlands) was used to visualize the Iba1 antibody.
After washing three times with PBS, retinal and RPE/choroidal
flat mounts were mounted with fluorescence mounting medium
containing Hoechst 33342 (Dako, Cambridgeshire,UK) and
images were obtained using a confocal laser scanning microscope
(Leica DM5500 Q, Leica Microsystems,Wetzlar, Germany). The
obtained Z-stack images were processed for 3D data visualization
using Imaris software (Bitplane, Zurich, Switzerland).
Statistical analysis
Statistical analyses were performed using GraphPad Prism 5 for
Windows (GraphPad Software Inc, La Jolla, USA).
Results
The early onset retinal degeneration in CCDKO mice
starts in the inferior outer nuclear layer
To identify the primary site of pathology and define secondary
consequences during disease progression, we evaluated the spatial
and temporal distribution of degenerative events in CCDKO line
[41] in comparison to age-matched C57Bl/6 mice between 1
month and 22 months of age. Autofluorescent fundus imaging by
scanning laser ophthalmoscopy (AF-SLO) demonstrated faint
abnormal autofluorescent fundus lesion at 1 months of age
(figure 1A, white arrowheads) that evolved to medium sized,
discrete disciform hyperfluorescent lesions at 4 months of age in
the inferior retina of CCDKO mice (figure 1A, black arrowheads).
C57Bl/6 mice of any age between 1 month and 20 months did not
exhibit similar lesions, but showed small, discrete autofluorescent
fundus spots (figure 1A, upper row, black arrows), which we have
previously described as a signal originating subretinal macrophag-
es containing lipofuscin in aged mice [40]. The number of the
inferior disciform lesions, which are more anterior located within
the retina than subretinal macrophages (data not shown), increase
with age and become confluent at later time points (figure 1A,
lower row, white arrow). This indicates that CCDKO mice show a
progressive early onset, inferior retinal degeneration that remains
constricted to a focal area of the inferior retina even up to very late
stages.
To further elucidate the location of autofluorescent fundus
lesions within the retina, we performed optical coherence
tomography (OCT, figure 1 B) in parallel to AF-SLO imaging
(figure 1 A) in CCDKO and age-matched C57Bl/6 controls between
1 and 22 months of age. CCDKO mice demonstrated abnormal
OCT signals in the outer retina in particular within the outer
nuclear (ONL) and the outer plexiform layer (OPL) which
corresponded spatially to the disciform autofluorescent fundus
lesions in the inferior retina (figure 1 B, white and black
arrowheads). In line with the SLO data, these OCT changes in
the inferior retina increase with age and lead to the disruption of
retinal layering as well as retinal thinning and degeneration at 8
month of age and older (white arrow in figure 1A and figure 1B).
C57Bl/6 control mice did not show any abnormal OCT signals at
any of the studied ages (1R20 months, upper row, Figure 1B).
Compared to this prominent, age-related progressive retinal
degeneration observed in the inferior retina, the superior retina
remained largely unaffected, despite some abnormal OCT signals
obtained from areas close to the optic disc (e.g. figure 1B, 8
months, middle row, black arrowhead). These also correlated with
some individual autofluorescent lesions observed in the AF-SLO
fundus images in the superior retina (e.g. figure 1A, 8 months,
lower row, black arrowhead). Taken together, these data indicate
that the retinal degeneration in CCDKO mice starts primarily
within the inferior outer retina and progresses in an age-dependent
manner to a focal loss of all retinal layers in the inferior retina.
The inferior localization of the retinal degeneration in
CCDKO mice is not dependent on light
The inferior localization of the retinal degeneration observed in
CCDKO mice suggested a possible role of light as an initiating or
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contributing factor for the development of the retinal degenera-
tion. To evaluate, whether light is a necessary factor for this
inferior retinal degeneration, we used autofluorescent SLO fundus
imaging and compared the phenotype of CCDKO mice at 8 weeks
of age which were raised from birth either in normal 12 h/12 h
light/dark cycle conditions (33628 lx during the light period) or in
complete darkness (luminescence ,0.5 lx). As an additional
control group we included wildtype C57Bl/6 mice raised under
12 h/12 h light/dark cycle conditions. Both groups of CCDKO
mice showed a very similar inferior localisation of autofluorescent
lesions at 8 weeks of age (Figure 2A), while control wildtype
animals do not show any of the typical autofluorescent lesions in
the inferior retina. This suggests that the manifestation of the
inferior retinal degeneration in CCDKO mice is independent of
light. To further evaluate, whether darkness might have attenuated
the inferior retinal phenotype in dark raised CCDKO mice, we
determined the number of autofluorescent lesions per fundus
image in all three groups (figure 2B). We did not detect a
significant difference in the number of autofluorescent lesions per
fundus image between both groups of CCDKO mice, but observed
a significantly higher number of autofluorescent lesions in CCDKO
mice in general compared to C57Bl/6 controls (Figure 2B, One-
way ANOVA p,0.001, Tukey’s Multiple comparison posthoc test
p,0.05). These data further support that the manifestation of the
inferior retinal degeneration in CCDKO mice is not dependent on
light and that ambient light levels (luminescence = 33628 lx) do
not modulate the retinal phenotype in CCDKO mice significantly
during the first 8 weeks of life.
Autofluorescent retinal fundus lesions in the inferior
retina are located in outer retinal layers and originate
from columns of degenerating photoreceptor nuclei
surrounded by recruited microglia
To further characterise the nature of the autofluorescent lesions
in CCDKO mice we compared the localisation of AF-SLO and
OCT lesions (Figure 1A and 1B) with that of lesions in retinal flat
mount preparations stained for blood vessel and microglia marker,
since microglia cells are known to be recruited to sites of retinal
degenerations and can be altered in chemokine knockout mice
(Figure 3 A, B, C, D, E, F, see also supplementary Movie S1
C57Bl6 and supplementary Movie S2 CCDKO).
At the level of the deep capillary plexus in the outer plexiform
layer (OPL, figure 3A and 3D), CCDKO mice demonstrated
relatively normal ramified microglia which showed a slightly more
Figure 1. CCDKOmice show an early onset, focal inferior retinal degeneration starting in the outer retina which subsequently leads
to a breakdown of retinal layering in the affected area with age. In vivo assessment of the retinal degeneration of CCDKO mice and age-
matched C57Bl/6 wildtype mice at 1,4,8,12,15 and older than 20 months of age using autofluorescence scanning laser ophthalmoscopy (A) and
optical coherence tomography (B). Note the weak autofluorescent fundus lesions in CCDKO mice visible as early as 1 month (A) which correlate with
the observation of an abnormal signal in the inferior OCT image at the same age (B) and suggests an early pathological event in the outer retina as
the basis of the degeneration in this model. Corresponding signals in AF-SLO and OCT images are labelled identically. White arrowheads: small early
inner retinal autofluorescent lesion, black arrowheads: discrete disciform autofluorescent lesion, white arrow: ‘‘confluent’’ autofluorescent lesion in
AF-SLO represents loss of retinal layering and severe retinal degeneration, black arrow: discrete autofluorescent spot-like lesion. GCL: ganglion cell
layer, OPL: outer plexiform layer, ONL: outer nuclear layer, RPE: retinal pigment epithelium.
doi:10.1371/journal.pone.0035551.g001
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swollen cell body than microglia in C57Bl/6mice at the same retinal
layer (white arrows in figure 3D (CCDKO) versus 3A (C57Bl/6)). In
the outer retina, however, CCDKOmice revealed microglia cells that
have migrated into the outer nuclear layer (figure 3E, 3F,
supplementary Movie S2 CCDKO) and are positioned around
circular columns of photoreceptor nuclei dropping out of the ONL
(white circle, figure 3F). In contrast, in C57Bl/6 mice microglia are
not present in the outer nuclear layer (ONL) or the inner segment
(IS) area (figure 3B, C, supplementary Movie S1 C57Bl6). The
observed degenerating columns of photoreceptor cells in CCDKO
mice together with the surrounding recruited microglia correspond
in location, size and configuration well with the disciform shape of
the autofluorescent fundus lesions observed in AF-SLO images
(figure 1A, black arrowheads) as well as with the OCT signals
observed in the outer retina of CCDKO mice (figure 1B, white and
black arrowheads). This data suggests that microglia in CCDKO
mice are recruited to the site of primary retinal lesions in the outer
retina of CCDKO mice and that this process and the lesion
development is reflected by these autofluorescent fundus lesions
observed in vivo by AF-SLO imaging.
Figure 2. The inferior retinal degeneration in CCDKO mice is not dependent on light. (A) Comparison of autofluorescent SLO fundus
images of CCDKOmice at 8 weeks of age that were raised from birth either in complete darkness (24 h dark, luminescence,0.5 lx) or in normal 12 h/
12 h light/dark cycle (light 12 h/12 h, luminescence = 33628 lx). As a comparison an AF-SLO fundus image from an aged-matched C57Bl/6 wildtype
mouse raised under normal 12 h/12 h light/dark cycle is shown. (B) Quantitative assessment of the number of autofluorescent lesions/per fundus
image for the three animal groups. The number of autofluorescent lesions in CCDKO (24 h dark, n = 9) and CCDKO (12 h/12 h light/dark, n = 9) was
not significantly different, but was significantly higher compared to that in C57Bl/6mice (12 h/12 h light/dark, n = 14). *: One-way-ANOVA (p,0.0001),
Tukey’s posthoc test for multiple comparison (p,0.05). This suggests that light is not necessary for the manifestation of the early onset inferior retinal
degeneration in CCDKO mice and that ambient light (33+228 lx) does not augment the number of inferior retinal autofluorescent lesions in CCDKO
mice within the first 8 weeks of their life.
doi:10.1371/journal.pone.0035551.g002
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A localized drop-out of ONL nuclei suggests a primary
retinal event to initiate the progressive inferior retinal
degeneration in CCDKO mice which leads to late
secondary RPE damage
To evaluate the histopathology and the progression of the
primary lesion and define secondary events during the retinal
degeneration of CCDKO mice, we examined superior-inferiorly-
oriented sagittal semithin sections for all age groups of CCDKO
mice and control C57Bl/6 mice. CCDKO mice demonstrate an
early mislocalisation of photoreceptor nuclei in the inferior outer
nuclear layer at two weeks of age indicating a very early onset of
retinal changes in the inferior outer retina (Figure 4 A, white
arrowheads). This phenotype becomes more prominent with age
and whole columns of ONL nuclei drop out of the outer nuclear
layer at 1 to 4 months of age (Figure 4A, white arrows). This leads
subsequently to a prominent focal loss of all retinal layers in the
inferior retina as well as to retinal thinning and scaring at ages
between 8 and 12 months. Due to the retinal thinning, descending
retinal vessels (figure 4A, black arrowheads) come in contact with
the RPE and form RPE/vascular lesions that might contribute to
retinal tractions and scaring. Within these lesions retinal vessels
break through the RPE but do not to link up to choroidal vessels
(see also figure 5 F, G, H and text below).
CCDKO mice have been reported to exhibit severe RPE damage
[47] and there are conflicting reports for the degree of RPE
changes with age in other Ccl2 and CCR2 single knockout strains
[38,40]. Therefore we aimed to elucidate the temporal onset of
RPE damage in CCDKO mice between 1 and 22 months of age in
order to understand, whether RPE damage is a primary or
secondary event during the course of the degeneration. By using a
previously described quantitative morphometry approach for
grading RPE damage in mice [40,45,48], we found that the
RPE damage in both, CCDKO and C57Bl/6 control mice
increased significantly with age (figure 4B, C57Bl/6: Pearson
correlation r2 = 0.5562, p,0.0001, N= 37; CCDKO mice: Pearson
r2 = 0.7115, p,0.0001; N=43). The age-dependent increase in
RPE damage in CCDKO mice was significantly higher compared
to C57Bl/6 mice indicating a disease related increase of RPE
damage in CCDKO mice (figure 4B, linear regression analysis,
slopes of the two curves are significantly different, p,0.0001). To
evaluate the onset of increased RPE damage in CCDKO mice we
compared the RPE damage score for each age group indepen-
dently. While the RPE damage of CCDKO mice compared to age-
matched C57Bl/6 mice between 1 month and 8 months was not
significantly increased, from 12 months onwards the RPE damage
was significantly higher in CCDKO (figure 4B, One way ANAVO
p,0.0001 with Bonferroni multiple comparison posthoc test
p,0.05 was not significant at 0.5 month (m): N=5/6; at 1 m:
N=3/5; at 4 m: N=6/4 and at 8 m: N=6/6, while it was
significant at 12 m: N=6/6; at 16 m: N=7/7; and at .20 m:
N=4/9). This indicates that the RPE is affected secondarily and
late during disease progression in CCDKO mice. In addition RPE
damage occurs in particular in the area of focal retinal
degeneration supporting that a primary retinal pathology leads
to RPE damage in CCDKO mice (figure 4A, see also figure 5 C, D,
E, F, G, H).
The focal inferior retinal degeneration in CCDKO mice
leads to the secondary development of vascular
malformation similar to retinal telangiectasia
Previous work has suggested, that chemokines and in particular
Ccl2 and Ccr2 [37,40,49] as well as Cx3cr1 signalling [29] play an
important role during the development of choroidal neovascular-
isation. Furthermore it has been reported that about 10–15% of
Figure 3. Microglia are recruited to the primary retinal lesions in the outer retina of CCDKOmice. Confocal maximum projection images
of a subset of images at different depth of the z-stack (A,C,D,F) and images of 3D-reconstructions (IMARIS) of corresponding complete z-stacks (B,E).
Z-stack images were taken from the inferior area of retinal flat mount preparations from CCDKO and C57Bl/6 mice at 2 months of age. The samples
were labeled with Tritc-lectinB4 (vascular marker, red), Iba1 (microglia marker, green) and DAPI as a nuclear counter stain (blue). OPL: outer plexiform
layer, ONL: outer nuclear layer, IS: inner segments. (A+D) At the level of OPL ramified microglia (green) are located between vessels of the deep
capillary plexus (red). Microglia of CCDKO mice (white arrows, D) show a slightly bigger cell bodies than those in C57Bl/6 mice (A). Microglia were also
observed in the outer retina of CCDKO mice in the 3D Imaris reconstruction (E) and in confocal z-projections from the outer retina (F) while they were
not observed in the outer retina of C57Bl/6 mice (B, C). microglia in the outer retina of CCDKO mice surround circular lesions (F, white circle) that may
correspond well with the disciform shape of autofluorescent lesion observed in AF-SLO fundus images.
doi:10.1371/journal.pone.0035551.g003
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CCDKO mice older than 3 months develop choroidal neovascu-
larisation based on histological analysis and the finding that vessels
breach the RPE [41]. To further understand the nature and the
development of the vascular phenotype of CCDKO mice in relation
to the progression of the retinal degeneration, we performed in vivo
fluorescein angiography in CCDKO mice and age-matched C57Bl/
6 mice between 1 month and 20 months of age (figure 5A).
Furthermore, we stained the vasculature in retinal and choroidal
flat mount preparation with TRITC-conjugated isolectin B4 and
analysed the vascular phenotype in CCDKO mice at different ages
(figure 5C, D, E). Fluorescein angiography was performed on the
same animals and in the same experimental session as the AF-SLO
imaging (figure 1A) and OCT (figure 1B), which enabled us to
directly compare the location of autofluorescent lesions and
vascular changes in these animals. During the early retinal
degenerative events at 1 month of age, CCDKO mice did not reveal
Figure 4. The primary degenerative event in the course of the degeneration is located in the outer nuclear layer of CCDKOmice and
leads to the secondary development of RPE damage. (A) Superior-inferior oriented sagittal semithin histology of the outer retina of CCDKO
mice and age-matched C57Bl/6 wildtype mice at the level of the optic disc between 2 weeks and over 20 months of age. A localized drop-out of
nuclei from the ONL (white arrowheads) as early as 2 weeks of age in CCDKO mice suggests a primary pathological event in the retina that initiates
the progressive inferior retinal degeneration in this model finally leading to the complete loss of retinal layers from 8 months of age onwards. The RPE
underneath these lesions is secondarily affected. White arrows: drop out of photoreceptor columns, black arrowheads: descending retinal vessels, INL:
inner nuclear layer, OPL: outer plexiform layer, ONL: outer nuclear layer, IS: inner segments, OS: outer segments, RPE: retinal pigment epithelium. (B)
Quantitative morphometry of RPE damage on the same sections. We observed an normal age-related increase of RPE damage in wildtype mice
(C57Bl/6: Pearson r2 = 0.5562, p,0.0001, N = 37) and observed that the age-related increase of RPE damage in CDDKO mice (CCDKO: Pearson
r2 = 0.7115, p,0.0001; N = 43) was significantly higher compared to C57Bl/6 mice (linear regression analysis, p,0.0001),which was significantly more
pronounced in CCDKO mice (Pearson r2 = 0.465,p = 0.0007; slope difference: p = 0.01). Nevertheless the RPE damage becomes only significantly higher
during late stages of the degeneration suggesting a secondary involvement of the RPE during the degenerative process. Scale bars: 25 mm.
doi:10.1371/journal.pone.0035551.g004
Chemokine Signalling Modulates Retinal Degeneration
PLoS ONE | www.plosone.org 8 April 2012 | Volume 7 | Issue 4 | e35551
Chemokine Signalling Modulates Retinal Degeneration
PLoS ONE | www.plosone.org 9 April 2012 | Volume 7 | Issue 4 | e35551
any vascular changes in compared with control mice (figure 5 A, 1
month). In fluorescein angiography, CCDKO mice older than 1
month of age showed prominent areas of fundus hyperfluores-
cence (figure 5A, white arrowheads), but only low-grade evasation
of fluorescein in the inferior retina during the late phase of the
angiography (,7 min, figure 5A, white arrowheads). These areas
of fundus hyperfluorescence were observed in the same areas as
the inferior retinal degeneration indicated in corresponding AF-
SLO and OCT images by autofluorescent lesions (figure 1A, 1B).
During later stages of disease, CCDKO mice demonstrate an
increasing penetrance of the late-phase hyperfluorescence with age
and about 50–74% of CCDKO mice exhibit such hyperfluorescent
areas at ages between 12–20 months (figure 5B).
Retinal flat mounts from CCDKO and age-matched wildtype
controls at 1 months, 12 months and 20 months imaged by
interference contrast (DIC) bright field microscopy revealed grey
spots in the inferior retina of 1 months old CCDKO animals
(figure 5C, black square and 5D, black arrowheads) which
correspond well to the location of autofluorescent lesions
(figure 1A, white arrowheads) and where absent in C57Bl/6
wildtype controls (figure 5C, upper row left and 5D, upper row
right). At later time points during disease progression, at ages of 12
months and 20 months, CCDKO mice show an increasing number
of pigmented cells located within the area of retinal degeneration
(figure 5C, black squares correspond to the areas from which
images in figure 5 D were taken). These pigmented cells are
pigmented RPE cells that are attached to the retina from the
subretinal side and have infiltrated along the retinal vasculature
that came in touch with the RPE (figure 5G, arrow). Only within
areas of pronounced inferior retinal degeneration at 12 month and
.20 months, we observed retinal vascular anomalies including
vessel tortuosity (figure 5D, white arrowhead e.g. at 12 months),
dilated vessels (figure 5D, white arrowhead, e.g. at .20 months)
and retinal vessels that were closely attached to the RPE, e.g.
shown on an apical image of an isolectin B4 stained RPE/
choroidal flat mount preparation to which the retinal vasculature
within the degenerate areas was attached (figure 5E, white arrow).
Three-dimensional reconstruction of tissue blocks within the
degenerate area of aged CCDKOmice by serial block-face scanning
electron microscopy (figure 5F–H) demonstrate that retinal vessels
within the degenerate area are severely abnormal (figure 5F) and
are directly connected to vessels that are positioned adjacent to
Bruch’s membrane underneath the RPE (figure F, G). RPE cells
show a migratory response along the descending retinal vessels
that leads to an RPE/Vascular complex in which RPE cells
surround retinal vessels within the retina (figure 5G, black arrow).
These vessel correspond in location well with the directly attached
retinal vasculature observed apically on the RPE/choroidal flat
mount (figure 5E, white arrow) and the localisation of RPE cells
within the retinal flat mount preparations in the area of
degeneration (figure 5C&D). Translocated retinal vessels that are
closely positioned adjacent to Bruch’s membrane do grow along
Bruch’s membrane within the lesion area, but have not been
observed, neither on the semithin sections nor in three different
ultrastructural reconstructions, to break through Bruch’s mem-
brane (figure 5H) suggesting that Bruch’s membrane remains
intact in the CCDKO mouse model even underneath very late
vascular lesions. These clinical, immunohistological and ultra-
structural data suggest that CCDKO mice develop vascular lesions
secondarily to the observed retinal degeneration. The vascular
anomalies are of retinal origin and do not connect to the choroidal
vasculature and rather share similarities with retinal telangiectasia
than with clinical features of choroidal neovascularisation.
The early onset, inferior retinal degeneration does
segregate independently of either of the chemokine
knockout alleles (Ccl2 or Cx3cr1) in an autosomal,
recessive Mendelian trait
To exclude a potential genetic background effect that might
contribute to some of the observed variability between different
chemokine knockout lines and to understand whether and how
combined defects in both chemokine pathways in CCDKO mice
contribute to retinal degeneration, we generated Ccl22/2,
Cx3cr12/2 and Ccl22/2/Cx3cr12/2 mouse lines by backcrossing
the original parental line with C57BL/6 mice (figure 6A). We set
up three independent F1 breeding pairs from offspring of our
parental crosses and obtain 85 F2 offspring. Genotyping of all 85
offspring for the Ccl2 and Cx3cr1 alleles resulted in all expected
genotype combinations in a ratio consistent with two independent
Mendelian traits (table 2).
By phenotyping a subset of the obtained chemokine knockout
mice (underlined in table 2) using autofluorescent AF-SLO
imaging, we observed that the typical autofluorescent fundus
lesions in these mice did not co-segregate with any of the
chemokine genotypes, but that the inheritance pattern for this
phenotype was consistent with an independent third autosomal
recessive locus in these mice (table 3).
Figure 5. Vascular lesions in CCDKO mice develop secondarily to the retinal degeneration and show similarities to retinal
telangiectasia rather than choroidal neovascularisation. (A) Late phase fluorescein angiography images of CCDKO mice and age-matched
wildtype mice between 1 month and over 20 months of age reveals a late phase (,7 min post i.p. injection) hyperfluorescence of fluorescein (white
arrowheads) secondary to the focal early onset, inferior retinal degeneration. (B) Quantification of the penetrance (%) of late stage hyperfluorescence
in CCDKO mice at different ages in comparison to C57Bl/6 mice. The number of animals (N) analysed per age group and genotype are shown in the
graph (N= eyes with late FFA hyperfluorescence/total number of imaged eyes). (C) DIC bright field images of retinal flat mount preparations of
CCDKO and age-matched wildtype controls at 1 months, 12 months and 20 months, scale bar: 750 mm. (D) Magnified DIC bright field images and
corresponding immunohistochemistry staining for the vascular marker isolectin B4 (TRITC-lectin-B4, red) taken from the affected inferior degenerate
areas (black squares in (C)).At 1 month, early separate grey spots (5D, black arrowhead) were observed inferior to the optic disc, which later grow
bigger, become confluent and involve pigmented cell attached to the focal inferior retinal lesion. Lectin-positive vessels within the area of
degeneration show vascular anomalies secondary to the retinal degeneration, including vascular tortuosity (5D, white arrowhead, at 12 months) and
dilation of retinal capillaries (5D, white arrowhead, at 20 months).Scale 150 mm. (E) Overlay of a bright field and immunohistochemistry image taken
from the apical side of a lectin-stained RPE/choroidal flat mount from a CCDKO mouse at 20 months of age. The retinal vasculature within the
degenerate area (white arrow) was closely attached to the underlying apical side of the RPE. Scale: 100 mm. (F–H): Different views of a three
dimensional reconstruction from a tissue block from the centre of an inferior retinal lesion of a CCDKO mouse at 20 months of age using serial block-
face scanning electron microscopy with a Gatan 3-View system. Connected vascular lumens are labeled by an identical color, while the location of
Bruch’s membrane in each ultrathin section is outlined by a pink line. Retinal vessels collapse onto the RPE and induce a migratory response of RPE
cells to grow along these vessels into the retina (black arrows). Retinal vessels grow underneath the RPE and become positioned in close vicinity to
Bruch’s membrane within a RPE/vascular complex, but they never have been observed to grow through Bruch’s membrane (Representative 3D
reconstruction images from a tissue block with the dimensions; x-axis 176.42 mm, y-axis 176.42 mm, z-axis: 39.9 mm, Scale (G&H): 50 mm.
doi:10.1371/journal.pone.0035551.g005
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Subsequent breeding of F2 mice using a combination of
autofluorescent fundus imaging at 8 weeks of age with genotyping
for both chemokine loci of all offspring (F3 generation) allowed us
to establish 6 independent chemokine knockout mouse lines. For
each chemokine genotype including Ccl2 single knockout mice
(Ccl22/2/Cx3cr1+/+), Cx3cr1 single knockout mice Ccl2+/+/
Cx3cr12/2), and the re-derived Ccl2/Cx3cr1 double knockout
mice (Ccl22/2/Cx3cr12/2) we established affected and an
unaffected mouse lines that either exhibit the typical autofluor-
escent fundus lesions at the age of 8 weeks or not (figure 6B). To
ensure, that we have not missed a late-onset phenotype developing
in either of the newly established chemokine lines, we also imaged
Figure 6. Ccl2 and Cx3cr1 as well as the genetic C57Bl/6 background differentially modulate the autosomal recessive early onset,
inferior retinal degeneration caused by the RD8 mutation in exon 9 of the Crb1 gene. In vivo phenotyping by autofluorescent fundus
imaging of the two parental (P) mouse lines (CCDKO and C57Bl/6) (A) as well as in the newly established chemokine knockout mouse lines (Ccl22/2,
Cx3cr12/2 and Ccl22/2/Cx3cr12/2) at the age of 2 months (2 M, B) and 6 months (6 M, C). Autofluorescent fundus lesions were observed
independently from the chemokine genotypes at the age of 2 months and 6 months suggesting that an independent genomic locus is responsible
for the early onset, inferior retinal degeneration. (D) Quantification of the number of autofluorescent lesions per fundus image for all parental,
affected and unaffected chemokine knockout mouse lines indicated significant differences in the number of autofluorescent fundus lesions between
the groups. The individual number of autofluorescent lesions per fundus and animal is shown together with the mean6 standard deviation. *: (One-
way-ANOVA p,0.0001, Tukey posthoc test for multiple comparison (p,0.05)). This data indicate an attenuating influence of increasing C57Bl/6
genetic background in all offspring obtained from the F2 generation relative to the parental CCDKO mouse line and thus were labelled as F3
generation. A differential modulatory effect of both chemokine signalling pathways on the severity of the retinal degeneration at 8 weeks of age was
also observed by comparing the three affected lines within the F3 generation. N (CCDKO original line P) = 7, N(C57Bl/6 wt P) = 19, N(Ccl22/2
affected) = 42, N(Ccl22/2 unaffected F3) = 23, N(Cx3cr12/2 affected F3) = 16, N(Cx3cr12/2 unaffected F3) = 71, N(new Ccl22/2/Cx3cr12/2 affected
F3) = 19, N(new Ccl22/2/Cx3cr12/2 unaffected F3) = 32.
doi:10.1371/journal.pone.0035551.g006
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animals of all these new lines at the age of 6–9 months and did not
observe any inferior autofluorescent lesion in all three ‘‘unaffect-
ed’’ lines, while we always observed typical autofluorescent
changes in the inferior part of the retina of animals from the
‘‘affected’’ lines (figure 6C). This strongly suggested that the early
onset, inferior retinal degeneration characterised by the appear-
ance of the typical disciform autofluorescent lesion in the inferior
retina is caused by a third genetic locus, that leads to a typical
retinal degeneration phenotype and indicates that the original
CCDKO double knockout mouse line for Ccl2 and Cx3cr1 actually
contains a third autosomal recessive retinal degeneration locus. By
genomic sequencing of affected and unaffected animals from all 6
lines, we found that the naturally occurring RD8 mutation, a
single base pair deletion in exon 9 of the Crb1 gene, co-segregates
100% with the observed early-onset inferior retinal degeneration
in the original CCDKO mouse line as well as in all three re-derived
‘‘affected’’ Ccl22/2, Cx3cr12/2 and Ccl22/2/Cx3cr12/2 ‘‘single’’
and ‘‘double’’ chemokine knockout mouse lines.
The genetic background as well as Ccl2 and Cx3cr1
chemokine ablation differentially modulates the retinal
degeneration caused by the autosomal recessive
homozygous Crb1RD8/RD8 mutation
The genetic proof of a third autosomal recessive locus by
breeding, genotyping and phenotyping of the lines as well as the
presence of Crb1-RD8 mutation in all affected lines, allowed us to
subsequently use these lines to assess the differential modulatory
effect of the genetic background and the two chemokine loci, Ccl2
and Cx3cr1, on the phenotype of the RD8 retinal degeneration in
offspring from the F2 generation. As a quantitative measure for the
retinal degeneration phenotype, we decided to use the number of
autofluorescent fundus lesions in AF-SLO fundus images at the
age of 8 weeks (figure 6D). We have shown above for the original
CCDKO mice (Ccl22/2, Cx3cr12/2, Crb1RD8/RD8) that these
fluorescent fundus lesion are an early in vivo indicator for typical
primary pathological events in the outer retina which led to the
recruitment of microglia. Thus, assessing the number of these
lesions might be a good measure for a potential modulatory effect
of the chemokine knockouts on the retinal degeneration phenotype
in vivo.
At 8 weeks of age, the original CCDKO line showed significantly
higher number of autofluorescent fundus lesions than normal
C57Bl/6 mice and all other 6 newly established chemokine
knockout mouse lines (figure 6D, One-way-ANOVA p,0.0001,
with Tukey’s posthoc test for multiple comparison (p,0.05)).
These include all the lines that carry a homozygous RD8 mutation
in combination with either of the single knockouts of Ccl2 or
Cx3cr1 as well as the newly established ‘‘affected’’ chemokine
double knockout mouse (Ccl22/2/Cx3cr12/2/Crb1RD8/RD8),
which has the same genotype as the original CCDKO line. This
clearly indicates that the retinal degeneration caused by a
homozygous Crb1RD8/RD8 mutation in these mouse lines is
attenuated by an increasing C57Bl/6 genetic background.
Furthermore, it became evident that the homozygous Crb1RD8/
RD8 mutation indeed causes the early onset retinal phenotype since
all mouse lines that carry the Crb1RD8/RD8 mutation (figure 6D,
‘‘affected’’) also show a significantly higher number of autofluor-
escent lesions in their fundus images not only compared to C57Bl/
6 control mice, but also in comparison to all the corresponding
single or double chemokine knockout mice (Ccl22/2, Cx3cr12/2,
Ccl22/2/Cx3cr12/2) that do not carry the Crb1RD8/RD8 mutation
(figure 6D ‘‘unaffected’’). Inversely, this shows that neither the
single nor the double knockout of the chemokines Ccl2 and/or
Cx3cr1 does lead to an early onset inferior retinal degeneration
since all unaffected lines show a similar very low number of any
autofluorescent lesions in the fundus as wildtype mice (figure 6D).
By comparing the affected mouse lines with each other we
observed that the re-derived Ccl22/2/Cx3cr12/2/Crb1RD8/RD8
mice (new Ccl22/2/Cx3cr12/2 affected F3) and Cx3cr12/2/
Crb1RD8/RD8 mice (Cx3cr12/2 (affected) F3) both showed similar
numbers of autofluorescent fundus lesions, which was for both
lines significantly higher that the number of autofluorescent fundus
lesions in Ccl22/2/Crb1RD8/RD8 mice (Ccl22/2 (affected) F3.
This suggests that absence of Cx3cr1 in either the single
(Cx3cr12/2/Crb1RD8/RD8) or the double chemokine knockout
(Ccl22/2/Cx3cr12/2/Crb1RD8/RD8) leads to a more pronounced
degenerative phenotype of the RD8 mutation than the RD8
mutation in combination with the knockout of Ccl2 (Ccl22/2/
Crb1RD8/RD8) alone. Furthermore this also shows, that there is no
significant additive affect of knocking Ccl2 out in addition to
Cx3cr1, since the double chemokine knockout of Ccl2 and Cx3cr1
(Ccl22/2/Cx3cr12/2/Crb1RD8/RD8) is not significantly increased
compared to the single knockout of Cx3cr1 (Cx3cr12/2/Crb1RD8/
RD8) (figure 6D).
To clarify, whether absence of Ccl2 signalling alone might also
have a modulatory effect on the RD8 retinal degeneration, we
evaluated littermates from the backcrosses that all carried the
Crb1RD8/RD8 mutation but were either homozygous wildtype
(Ccl2+/+/Crb1RD8/RD8), heterozygous (Ccl2+/2/Crb1RD8/RD8) or
homozygous knockout (Ccl22/2/Crb1RD8/RD8) for the Ccl2 locus
(figure 7). These animals were obtained from two specific breeding
pairs whose parental mice were heterozygous for Ccl2, wildtype for
Cx3cr1 and homozygous for the RD8 mutation (Ccl2+/2/
Cx3cfr1+/+/Crb1RD8/RD8). All offspring with any of the Ccl2
genotype combinations showed a significantly smaller number of
autofluorescent lesions in the fundus compared to the original
CCDKO mice (figure 7). This reflects the combinatory effect of the
additional C57Bl/6 genetic background and of the homozygous
Cx3cr12/2 knockout allele on the retinal degeneration caused by
the homozygous RD8 alleles (figure 7). Compared with indepen-
dent C57Bl/6 wildtype mice (figure 7, C57Bl/6 wt), littermates
from the backcross that carried the homozygous RD8 mutation,
but were wildtype (figure 7, Ccl2+/+/Crb1RD8/RD8) or heterozygous
(figure 7, Ccl2+/2/Crb1RD8/RD8) for Ccl2 showed a significantly
Table 2. Genotype distribution for both chemokine knockout
alleles in the F2 generation obtained from three independent
F1 breeding pairs during the backcross of the original CCDKO
mice with C57Bl/6 mice.
Genotype for
Ccl2 and
Cx3cr1 Ccl2+/+ Ccl2+/2 Ccl22/2 Sum
Cx3cr1+/+ 13 20 11 44
Cx3cr1+/2 5 18 5 28
Cx3cr12/2 5 6 2 13
Sum 23 44 18 85
The number of animals with respective genotype combinations for both
chemokine loci is shown in the field at crossing of columns (Ccl2 genotype) and
rows (Cx3cr1 genotype). Founder animals for newly re-derived Ccl2, Cx3cr1
single and Ccl2/Cx3cr1 double knockout lines are underlined.
doi:10.1371/journal.pone.0035551.t002
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higher number of lesions in the fundus, while Ccl2 deficient
littermates (figure 7, Ccl22/2/Crb1RD8/RD8) show no significant
difference compared with all three groups at 8 weeks of age.
Therefore this data suggests that Ccl2 does not have a significant
effect on the manifestation of the early onset retinal degeneration
in mice that carry a homozygous RD8 mutation, although we
cannot exclude a mildly protective effect of Ccl2 deficiency.
Discussion
In this study, we aimed to identify primary and secondary
pathological events during the previously described early onset
retinal degeneration in Ccl2/Cx3cr1 double knockout (CCDKO)
mouse line and to understand whether and how these two
Table 3. The distribution of the inferior autofluorescent fundus lesions in phenotyped animals of the F2 generation suggests that
this phenotype segregates independently from either of the chemokine loci in an autosomal recessive fashion.
Genotype N (F2 animals phenotyped)
N (F2 animals with inferior AF
lesions)
N (F2 animals without inferior AF
lesions)
Ccl22/2/Cx3cr1+/+ 6 2 4
Ccl2+/+/Cx3cr12/2 5 2 3
Ccl22/2/Cx3cr12/2 2 0 2
All F2 animals 13 (100%) 4 (31%) 9 (69%)
doi:10.1371/journal.pone.0035551.t003
Figure 7. Modulatory effect of the Ccl2 locus genotype (Ccl2+/+, Ccl2+/2, Ccl22/2) on the appearance of autofluorescent fundus lesions
in Crb1RD8/RD8 mice. Quantification of number of autofluorescent lesions/fundus image and littermate (n= ) according to the Ccl2 genotype and in
comparison to the parental strains (CCDKO and C57Bl/6mice). These findings indicate that the Ccl2 locus does not significantly modulate the severity of
RD8 induced retinal degeneration although we can not exclude a mild influence due to the intermediate position of the Ccl22/2/Crb1RD8/RD8 group. *:
indicates significant difference between the indicated groups (One-way-ANOVA p,0.0001, Tukey’s posthoc test for multiple comparison (p,0.05)). n.s.:
not significant. N (CCDKO original line P) = 7, N(C57Bl/6 wt P) = 14, N(Ccl2+/+/Crb1RD8/RD8) = 15, N(Ccl2+/2/Crb1RD8/RD8) = 31, N(Ccl22/2/Crb1RD8/RD8) = 10.
doi:10.1371/journal.pone.0035551.g007
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chemokine pathways contribute to the retinal degeneration [41].
We show that the early onset retinal degeneration in the original
CCDKO mouse line [41] is focally localised in the inferior retina
and that the primary pathological event is an early drop out of
nuclei from the outer nuclear layer. The RPE and the retinal
vasculature are affected secondarily at later stages during disease
progression. These findings are consistent with a very recent report
from another group which also identified primary lesions near the
outer limiting membrane in the same CCDKO line and suggested
an involvement of Mu¨ller cells in disease progression [50]. We now
provide evidence that the early onset retinal degeneration,
observed in these CCDKO knockout mouse lines as well as in all
re-derived ‘‘affected’’ Ccl2 and Cx3cr1 and Ccl2/Cx3cr1 double
knockout mice, is caused by a third independent autosomal
recessive locus. Re-derived Ccl2 or Cx3cr1 single knockout lines
and re-established Ccl2/Cx3cr1 double knockout mice which do
not carry the third locus exhibited no signs of an early onset retinal
phenotype. This indicates that neither Ccl2 nor Cx3cr1 deficiency
alone nor the combined double knockout of both chemokines
leads to a pronounced early onset retinal degeneration. In addition
we showed by genomic sequencing that the naturally occurring
homozygous RD8 mutation co-segregates with the early onset
retinal phenotype in all affected chemokine lines. This naturally
occurring RD8 (Crb1RD8/RD8) mutation is a single base pair
deletion of a cytosine in exon 9 of the Crb1 gene that causes a
frame shift and premature stop codon in the Crb1 protein which
lead to a truncated transmembrane and cytoplasmic domain of
Crb1 [51]. Crb1 is a key regulator of epithelial cell polarity and
contributes to the assembly of the zonula adherens, a belt like
adherent junction that separates apical and basolateral mem-
branes [51]. In the retina, Crb1 resides in Mu¨ller cells and is
crucially involved in the formation of the outer limiting membrane
at the posterior site of the outer nuclear layer of the retina. Lack of
Crb1 protein in Crb1RD8/RD8 mice leads to very similar phenotypic
features as we have observed in CCDKO mice. These include the
early onset inferior fundus lesions, a discontinuous outer limiting
membrane, an early dropout of nuclei from the outer nuclear layer
as well as the subsequent focal age-related retinal dysplasia which
is secondarily associated with vascular lesions in the outer retina
[51–53]. Furthermore, also our observation that the initiation of
the inferior retinal degeneration in CCDKO mice is independent
from light is consistent with previous data for Crb12/2 knockout
mice. These mice, when raised in complete darkness for 6 months
also show a similar degree of retinal degeneration as Crb12/2 mice
raised under normal lighting conditions (100 lux) [53]. However,
increased white fluorescent light levels of 3000 lux for 72 hours
promote the retinal degeneration in Crb12/2 mice [52] suggesting
that the ambient light conditions, we used in this study for CCDKO
mice are about 100fold lower than light levels necessary to
modulate the phenotype of this type of retinal degeneration. These
data suggest, that the inferior location of the retinal degeneration
in Crb1 mutant mice (Crb1RD8/RD8, Crb12/2 and CDDKO mice) is
not due to the influence of light, but due to an unknown factor that
restricts the photoreceptor degeneration to the inferior retina.
These pronounced similarities in the phenotype as well as the co-
segregation of the Crb1RD8/RD8 mutation with the early onset
retinal degeneration in the different re-derived chemokine
knockout mice indicate that the retinal degeneration observed in
original CCDKO mice is the consequence of the Crb1RD8/RD8
mutation and not due to the combined double knockout of Ccl2
and Cx3cr1 as previously reported [41].
Late stage retinal degeneration in Ccl22/2/Cx3cr12/2/
Crb1RD8/RD8 mice leads to the development of retinal
vascular lesions similar to retinal telangiectasia
The identification of the Crb1RD8/RD8 mutation as the underlying
cause for the early onset retinal degeneration in CCDKO mice
enables us to better interpret the observed secondary degenerative
events in original CCDKO mice. The two major secondary events
observed in the Ccl22/2/Cx3cr12/2/Crb1RD8/RD8 mice with age
include RPE changes and closely associated vascular lesions in the
area of retinal degeneration. The vascular lesions contained
tortuous and dilated vessels in the area of retinal degeneration
and showed an increasing penetrance of late phase hyperfluores-
cence in fluorescein angiography which indicates a low grade
vascular inflammation and a low grade late vascular leakiness of
retinal vessels within the lesions. Using serial block-face scanning
electron microscopy (SB-SEM) and 3D reconstruction, we demon-
strated that the retinal vessels within the degenerate area break
through the RPE layer and come in close contact with Bruch’s
membrane, but do not penetrate it. This abnormal location of
retinal vessels seems to induce a secondary response of RPE cells
which migrate along those vessels into the retina and ensheath them
within the RPE/vascular lesion. However, the fact that not all aged
CCDKO mice showed the occurrence of the late phase hyperfluor-
escence in the fluorescein angiography suggests that the manifes-
tation of this vascular phenotype is variable and thus likely not a
primary consequence of the RD8 mutation, but rather a secondary
process dependent on the individual severity of the progression of
the retinal degeneration. Based on the clinical observations (late
phase FFA hyperfluorescence, tortuous and dilated vessels within
the degenerate areas of the retina) as well as on the basis of our
ultrastructural observations, that vessels of retinal origin grow
underneath the RPE but do not penetrate Bruch’s membrane, we
propose that the vessels within the RPE/vascular lesions in the
Ccl22/2/Cx3cr12/2/Crb1RD8/RD8 mice are similar to retinal
telangiectasia rather than choroidal neovascularisation, which was
reported to occur in about 10–15% of the original CCDKO mouse
line above the age of 3 months [41]. Our findings are also consistent
with the recently reported stabilization of the lesion phenotype by
virus mediated overexpression of sFLT1 which might attenuate the
secondary low grade vascular inflammation and leakiness during
disease progression and thus might lead to the reported beneficial
outcome for CCDKO mice [43].
Since the late stage secondary changes in CCDKO mice are also
very similar to those in aged Crb1RD8/RD8 mice [53], we suggest
that Crb1RD8/RD8 mice might show similar vascular lesions as
described here and do not develop CNV. Our data supports the
view that vascular lesions in patients with Crb1 mutations, that
show Coat’s-like exudates in the inferior region of the retina, are
likely to be more similar to retinal telangiectasia with similar
vascular features as observed in this study, than choroidal
neovascularisation [54]. Future ultrastructural studies using serial
block-face scanning electron microscopy- (SB_SEM) and 3D
reconstruction may help to elucidate the nature of vascular lesions
in both Crb1RD8/RD8 mice as well as in patients with Crb1
mutations. A similar process in which retinal vessels are located
adjacent to Bruch’s membrane and are covered by RPE cells has
been described in late stage retinal degeneration in rhodopsin
knockout mice [55] suggesting that the development of this type of
RPE/vascular lesions may be not only specific to retinal
degeneration caused by mutations in Crb1, but might be more
common during late stages of other severe retinal degenerations.
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Genetic background modulates the retinal degeneration
caused by RD8 mutation in CCDKO mice
Our data demonstrates that genetic backcrossing of the CCDKO
mice to a C57Bl/6 genetic background attenuates the observed
retinal degeneration in CCDKO mice. The data suggest that the
genetic background of C57Bl/6 is a strong modulator of the
manifestation of retinal degeneration in all affected chemokine
knockout mice carrying the Crb1RD8/RD8 mutation and indicates
that other genetic factors influence the observed phenotype. The
presence of other genetic modifiers is also supported by the high
degree of phenotypic variability observed within each affected
mouse lines. Our findings are consistent with the original
characterisation of Crb1RD8/RD8 mice, which demonstrated that
the retinal degeneration is strongly modulated by backcrosses into
C57Bl/6, CAST/EiJ or C3HfB6/Ga mice. Interestingly, only the
discontinuous outer limiting membrane phenotype in Crb1RD8/RD8
mice remained preserved after backcrossing [51] supporting that
this may be the primary consequence of the Crb1RD8/RD8 mutation
in Ccl22/2/Cx3cr12/2/Crb1RD8/RD8 mice in this study as well.
Ccl2 and Cx3cr1 chemokine signalling differentially
modulate retinal degeneration in Crb1RD8/RD8 mice
Our data demonstrates that the genetic inactivation of either
Ccl2 and/or Cx3cr1 chemokine signalling differentially modulates
the severity of the retinal degeneration caused by the Crb1RD8/RD8
mutation at 8 weeks of age. This is supported by the observation
that all Cx3cr1 deficient lines that carry the Crb1RD8/RD8 mutation,
including the Ccl22/2/Cx3cr12/2/Crb1RD8/RD8 and Cx3cr12/2/
Crb1RD8/RD8 mice, exhibit a more severe retinal degeneration
compared to the Ccl22/2/Crb1RD8/RD8 line of the same backcross
generation and age. In contrast, Ccl2 deficiency (Ccl22/2/
Crb1RD8/RD8) alone does not significantly influence the retinal
degeneration caused by the Crb1RD8/RD8 mutation, although we
can not exclude a slight protective effect of it based on the trend
for a reduced number of autofluorescent lesions in Ccl2 deficient
mice (Ccl22/2/Crb1RD8/RD8) compared to heterozygous (Ccl2+/2/
Crb1RD8/RD8) or wildtype (Ccl2+/+/Crb1RD8/RD8) littermates. Ccl2
deficiency also does not significantly add to the exacerbated retinal
degeneration seen in Cx3cr12/2/Crb1RD8/RD8 mice suggesting that
the effects of Ccl2 and Cx3cr1 signalling defects do not act
synergistically on the manifestation of the retinal degeneration in
Crb1RD8/RD8 mice. A modulatory influence of either of the two
chemokine pathways and in particular of Cx3cr1 signalling on
retinal degenerations, is further supported by the observation that
Iba1+ microglia cells, which express Cx3cr1 in the retina [1], are
recruited to the primary site of pathology and interact with the
degenerating cells in the outer retina.
Our findings support the hypothesis that in original CCDKO line
and in other affected chemokine lines in this study, the defective
formation of the outer limiting membrane due to mutations in
Crb1 acts as an endogenous trigger for the local upregulation of
inflammatory mediators. This hypothesis is consistent with the
increased expression of Cx3cl1 in retinal and choroidal vascular
endothelial cells, Mu¨ller cells, RPE as well as photoreceptors after
inflammatory processes [56] as well as with the observed
upregulation of Ccl2 in Mu¨ller cells within affected retinal areas
after focal light injury and after retinal detachment [57,58]. Both,
Ccl2 as well as Cx3cl1 provide chemotactic cues for the local
recruitment of microglia and systemic monocytes to the primary
focal lesion site [12,23,59] and are part of a local chemokine
signalling network between photoreceptor cells and Mu¨ller cells
that controls the local recruitment and activation of microglia and
systemic macrophages in the retina. Dependent on which and how
severely each of the chemokine pathways are affected by
endogenous genetic variants within this cellular signalling network,
the responses of recruited microglia or monocytes will differ and
can either exacerbate retinal degeneration, as observed for Cx3cr1
deficient mice in combination with the Crb1RD8/RD8 mutation, or
may act mildly protective as eventually indicated by the trend
towards a slight reduction in lesion size in Ccl2 deficient mice
which also carry the Crb1RD8/RD8 mutation.
Further support for this idea comes from convincing evidence
for a microglia-mediated neurotoxicity in Cx3cr1 knockout mice in
the brain, where an increased neurotoxicity of brain microglia on
surrounding neurons has been observed after systemic inflamma-
tion induced by LPS [28]. In the retina, Cx3cr1 deficiency leads to
a reduced dynamic behavior of retinal microglia during immune
surveillance as well as during injury response [30]. It has also been
found to be associated with an increased photoreceptor degener-
ation during ageing and after light exposure [29] supporting the
hypothesis that Cx3cr1 deficient microglia can be neurotoxic in the
retina as well and have the capacity to act as modulators of retinal
degeneration as suggested by our observation. Therefore, we
hypothesise that the additional neurotoxic effect of Cx3cr1
deficiency on the retinal degeneration caused by the Crb1RD8/RD8
mutation might be due to an impaired migratory capability and a
subsequent reduced removal of dying photoreceptors by Cx3cr1-
deficient microglia which might result in the production of more
neurotoxic inflammatory mediators including Ccl5, TNFa or IL-6,
which may negatively affect photoreceptor cell survival, and have
all been previously shown to be upregulated in CCDKO mice
[28,30,42,60,61]. In contrast to the effect of Cx3cr1 deficiency, Ccl2
deficiency does not significantly modulate the manifestation of the
Crb1RD8/RD8 phenotype. This minor role of Ccl2 on the RD8
retinal degeneration seems consistent with our previous observa-
tion that Ccl2 deficiency does not lead to a significant associated
age-related retinal degeneration despite an accumulation of
subretinal, dysfunctional macrophages [40] and may be explained
by a minor role of Ccl2 in this process or by a compensatory effect
of other chemokine ligands that can bind to and activate CCR2
[19]. However, a slightly but not significantly reduced number of
autofluorescent lesions in Ccl22/2/Crb1RD8/RD8 mice may suggest
a mild protective effect of Ccl2 deficiency, which would be in line
with Ccl2’s role for the transendothelial migration of pro-
inflammatory monocytes across the blood brain barrier [25]. This
process could be similar to the protective effect of Ccl2 and Ccr2
deficiencies for the formation of atherosclerosis that lead to a
reduction of the formation of foam cells due to a reduced
recruitment of systemic myeloid cells to the site of the lesion in the
periphery [62].
Taken together, our study provides evidence for a differential
modulatory role of Ccl2 and Cx3cr1 chemokine signalling for the
inherited retinal degeneration caused by the Crb1RD8/RD8 mutation
and suggests that these two chemokine pathways not only
modulate age-related degenerative processes or acute inflamma-
tion in the retina, but also contribute to the pathology of inherited
retinal degenerations. Therefore it seems likely that these two
chemokine signalling pathways and maybe the innate immune
status of myeloid cells might act as a modifier for CRB1 mutations
in humans and thus contribute to the high phenotypic variability
observed in patients with different CRB1 mutations that either lead
to Lebers congenital amaurosis (LCA), early onset childhood
retinal dystrophy or juvenile onset retinitis pigmentosa [54].
Recent reports of increased CCL2 levels and reduced expression of
Cx3cr1 on non-classical monocytes in aged probands as well as
further increased levels of CCL2 in aqueous humor samples from
patients with exudative AMD [35,36] and in patients with
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advanced proliferative diabetic retinopathy [63] suggest that these
two chemokine pathways reveal an age-related shift from CX3CL1-
CX3CR1 signalling to increased CCL2-CCR2 signalling systemically
with age which might contribute to an increased susceptibility to
retinal degeneration with age and during disease progression of
multi-factorial age-related retinal diseases including AMD and
diabetes. Understanding further the role and interaction of
chemokine signalling pathways for the control of monocytes and
microglia cell in degenerative processes of the retina might help to
develop more targeted therapeutic approaches to modulate the
progression of inherited and other age-related, multi-factorial
retinal degenerations.
Supporting Information
Movie S1 C57Bl/6. Animation of 3D-reconstructions (IMA-
RIS) of confocaol Z-stack images taken from the inferior area of a
retinal flat mount of a C57Bl/6 mouse at 2 months of age. The
volume of the z-stack (x = 183.3 mm, y= 183.3 mm, z= 76 mm)
comprises the deep retinal vascular plexus, the outer nuclear layer
and part of the inner segments. The deep retinal vascular plexus
was labeled with Tritc-lectinB4 and is represented in red, while
retinal microglia labeled with Iba1 are shown in green. At the top
of the z-stack microglia located at the level of the deep retinal
vascular plexus show a normal ramified morphology. These cells
are not present in the outer retina. The red and green Imaris
surfaces in the area of the inner segments at the bottom of the z-
stack represent autofluorescent signals from photoreceptors.
(AVI)
Movie S2 CCDKO. Animation of 3D-reconstructions (IMA-
RIS) of confocaol Z-stack images taken from the inferior area of a
retinal flat mount of a CCDKO mouse at 2 months of age. The
volume of the z-stack (x = 183.3 mm, y= 183.3 mm, z= 76 mm)
comprises the deep retinal vascular plexus, the outer nuclear layer
and part of the inner segments. The deep retinal vascular plexus
was labeled with Tritc-lectinB4 and is represented in red, while
retinal microglia labeled with Iba1 are shown in green. At the top
of the z-stack microglia located at the level of the deep retinal
vascular plexus show thicker cell bodies compared to wildtype. In
addition microglia are also observed in the outer retina in distinct
columns. These microglia columns are observed in areas were the
inner segment autofluorescence (at the bottom of the z-stack) is
absent indicating altered photoreceptor positions or drop out.
(AVI)
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